title: Peptide T and glucose metabolism in AIDS dementia complex.
abstract: AIDS dementia complex (ADC) is the most common presenting neurologic manifestation of human immunodeficiency virus (HIV)-1 infection. We report FDG-PET studies in a 39-year-old man who had ADC and completed a 12-wk treatment protocol with 1.2 mg/day of intranasal peptide T, one before and one after 12 wk of treatment with peptide T. Peptide T is an octapeptide under investigation for treatment of ADC patients. Values of rCMRglc were converted to Z scores using the mean and standard deviation of values of rCMRglc in three HIV-seronegative matched controls, each of which was studied twice, at the beginning and end of a 12-wk interval. Thirty-five of 60 regions assayed showed Z scores with absolute values > or = 3 (considered abnormal) in the baseline study. Regions with high absolute values of Z scores were located in subcortical areas and in the limbic system, and to a lesser degree in the frontal, temporal and parietal lobes. Thirty-four of these 35 regions showed remission (decrease in the absolute values of Z scores) after treatment. Only one region showed no improvement in the second study. Three regions with absolute values of Z scores < 3 in the baseline study manifested Z scores with magnitudes > or = 3 in the second study. These preliminary observations suggest that functional neuroimaging techniques provide a useful tool in the evaluation of the response to treatment in ADC patients.
authors.affiliation: Brain Imaging Section, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Baltimore, Maryland 21224, USA.
authors.forename: V L
authors.initials: VL
authors.lastname: Villemagne
authors.forename: R L
authors.initials: RL
authors.lastname: Phillips
authors.forename: X
authors.initials: X
authors.lastname: Liu
authors.forename: S F
authors.initials: SF
authors.lastname: Gilson
authors.forename: R F
authors.initials: RF
authors.lastname: Dannals
authors.forename: D F
authors.initials: DF
authors.lastname: Wong
authors.forename: P J
authors.initials: PJ
authors.lastname: Harris
authors.forename: M
authors.initials: M
authors.lastname: Ruff
authors.forename: C
authors.initials: C
authors.lastname: Pert
authors.forename: P
authors.initials: P
authors.lastname: Bridge
authors.forename: E D
authors.initials: ED
authors.lastname: London
mesh_terms: D015526:AIDS Dementia Complex / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000378:metabolism; D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism*; D016022:Case-Control Studies; D003847:Deoxyglucose / Q000031:analogs & derivatives*; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D008297:Male; D015717:Peptide T / Q000627:therapeutic use*; D013997:Time Factors; D014055:Tomography, Emission-Computed
chemical_list: D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D015717:Peptide T; D003847:Deoxyglucose; D005947:Glucose